During the past decade, The Third Xiangya Hospital of Central South University conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 16 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 112 clinical trials started and 12 clinical trials were completed. i.e. 10.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Third Xiangya Hospital of Central South University" #1 sponsor was "The Third Xiangya Hospital of Central South University" with 31 trials, followed by "Jiangsu HengRui Medicine Co., Ltd." with 9 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Pfizer" with 7 trials sponsored and "BeiGene" with 7 trials sponsored. Other sponsors include 129 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Xiangya Hospital of Central South University" #1 collaborator was "The Third Xiangya Hospital of Central South University" with 13 trials as a collaborator, "Beijing Shijitan Hospital, Capital Medical University" with 5 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 5 trials as a collaborator, "Qilu Hospital of Shandong University" with 5 trials as a collaborator and "Xiangya Hospital of Central South University" with 5 trials as a collaborator. Other collaborators include 316 different institutions and companies that were collaborators in the rest 258 trials.

According to Clinical.Site data, the most researched conditions in "The Third Xiangya Hospital of Central South University" are "Atopic Dermatitis" (4 trials), "Hypertension" (4 trials), "Analgesia" (3 trials), "Blood Transfusion Complication" (3 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "The Third Xiangya Hospital of Central South University" in a lesser frequency.

Most popular intervention types in "The Third Xiangya Hospital of Central South University" are "Drug" (127 trials), "Device" (17 trials), "Other" (17 trials), "Procedure" (17 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Propofol" (4 trials), "Cisplatin" (3 trials), "Rituximab" (3 trials) and "Sevoflurane" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Third Xiangya Hospital of Central South University" are 179 trials for "All" genders, 8 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "The Third Xiangya Hospital of Central South University". 4 are not yet recruiting, 60 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in The Third Xiangya Hospital of Central South University, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Third Xiangya Hospital of Central South University, 17 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 38 trials that are defined as “Not Applicable".